World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
72
Citations
20134
World Ranking
1735
National Ranking
148

Medicine

D-Index
78
Citations
22113
World Ranking
18049
National Ranking
1646

Diana M. Gibb publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Diana M. Gibb sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 374 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Diana M. Gibb D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Diana M. Gibb sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 72 D-Index — 69th percentile

69% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Diana M. Gibb is affiliated with University College London in the United Kingdom. Their research primarily focuses on medicine, with particular expertise in infectious diseases, epidemiology, pediatrics, perinatology and child health, virology, and surgery.

The researcher has contributed extensively to several key topics within the medical field. These include:

  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • HIV-related health complications and treatments
  • Tuberculosis Research and Epidemiology
  • Pharmacological Effects and Toxicity Studies

Among Diana M. Gibb's recent papers are the following contributions:

  • Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia, 2021, published in JAMA
  • Neuroimaging young children and associations with neurocognitive development in a South African birth cohort study, 2020, published in NeuroImage
  • Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial, 2020, published in The Lancet HIV
  • Xpert MTB/RIF Ultra for the Diagnosis of Tuberculous Meningitis: A Small Step Forward, 2020, published in Clinical Infectious Diseases
  • CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies, 2020, published in Clinical Infectious Diseases

Frequent coauthors in Diana M. Gibb's body of work include:

  • Anna Turkova
  • Alasdair Bamford
  • Mutsa Bwakura-Dangarembizi
  • Victor Musiime
  • David M. Burger

The most common venues for their publications are:

  • Clinical Infectious Diseases
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Wellcome Open Research
  • The Lancet HIV
  • Journal of the International AIDS Society

Best Publications

  • Mortality after Fluid Bolus in African Children with Severe Infection

    Kathryn Maitland;Sarah Kiguli;Robert O. Opoka;Charles Engoru

  • Early Antiretroviral Therapy and Mortality among HIV-Infected Infants

    Avy Violari;Mark F. Cotton;Diana M. Gibb;Abdel G. Babiker

  • Mother-to-Child Transmission of Hepatitis C Virus: Evidence for Preventable Peripartum Transmission

    D. M. Gibb;R. L. Goodall;D. T. Dunn;M. Healy

  • Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial

    C Chintu;GJ Bhat;AS Walker;V Mulenga

  • Selective versus universal antenatal HIV testing: epidemiological and implementational factors in policy choice.

    A. E. Ades;Ramyani Gupta;Diana M Gibb;Trinh Duong

  • Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial

    Mark F Cotton;Avy Violari;Kennedy Otwombe;Ravindre Panchia

  • Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

    Unknown

  • Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial

    Kathryn Maitland;Elizabeth C George;Jennifer A Evans;Sarah Kiguli

  • Decline in mortality, AIDS, and hospital admissions in perinatally HIV-1 infected children in the United Kingdom and Ireland.

    D M Gibb;T Duong;P A Tookey;M Sharland

  • Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care.

    Ali Judd;Katja Doerholt;Pat A. Tookey;Mike Sharland

  • Mother-to-child transmission of the human immunodeficiency virus.

    Catherine Peckham;Diana Gibb

  • Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.

    Diana M. Gibb;Ruth L. Goodall;Vania Giacomet;Laura Mcgee

  • Enhanced prophylaxis plus antiretroviral therapy for advanced HIV infection in Africa.

    J Hakim;V Musiime;AJ Szubert;J Mallewa

  • Early antiretroviral therapy improves neurodevelopmental outcomes in infants

    Laughton B;Cornell M;Grove D;Kidd M

  • Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy.

    Marietta Charakida;Ann E. Donald;Hannah Green;Clare Storry

  • Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial.

    Diana M. Gibb;Hilda Kizito;Elizabeth C. Russell;Ennie Chidziva

  • Severe Renal Dysfunction and Risk Factors Associated with Renal Impairment in HIV-Infected Adults in Africa Initiating Antiretroviral Therapy

    Andrew Reid;Wolfgang Stöhr;A. Sarah Walker;Ian G. Williams

  • PENTA guidelines for the use of antiretroviral therapy, 2004.

    M Sharland;S Blanche;G Castelli;J Ramos

  • Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa

    P. Kaleebu;D. Pillay;A. S. Walker;V. Robertson

  • First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.

    Linda Harrison;Abdel Babiker;Hannah Castro;Alexandra Compagnucci

  • PENTA 2009 guidelines for the use of antiretroviral therapy in paediatric HIV-1 infection.

    M Sharland;G Castelli Gattinara di Zub;J Tomas Ramos;S Blanche

Frequent Co-Authors

Nigel Klein
Nigel Klein University College London
Cissy Kityo
Cissy Kityo Joint Clinical Research Centre
David M. Burger
David M. Burger Radboud University
Charles F. Gilks
Charles F. Gilks University of Queensland
A. Sarah Walker
A. Sarah Walker University of Oxford
Carlo Giaquinto
Carlo Giaquinto University of Padua
David Dunn
David Dunn University College London
Mike Sharland
Mike Sharland St George's, University of London
Janet Seeley
Janet Seeley London School of Hygiene & Tropical Medicine
Peter Mugyenyi
Peter Mugyenyi Uganda National Academy of Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree related to Microbiology opens doors to various online programs and career options. Many students explore medical programs online to complement their microbiology background with practical healthcare knowledge. These programs offer flexibility and are designed to accommodate busy schedules, making them an attractive option for working professionals.

For those interested in public health aspects, some opt for an easiest MPH online programs to get into. These programs can provide a streamlined path into public health careers without extensive entry barriers, blending well with microbiology studies focused on disease prevention and control.

Beyond traditional science roles, there are unique paths such as becoming a child life specialist, where understanding health and development is crucial. Information about the child life specialists salary highlights the potential financial benefits of entering this field.

Additionally, those with unconventional backgrounds might find hope in various college degrees for felons programs, which can open new educational and career opportunities. Online learning platforms offer inclusive pathways for many learners aiming to advance in microbiology-related fields.

Best Scientists Citing Diana M. Gibb

Trending Scientists

Recently Published Articles